MedinCell SA (MEDCL) Stock Statistics & Valuation Metrics

MedinCell SA has a market cap or net worth of €466.60M. The enterprise value is €477.04M.

MedinCell SA has 33,072,746 shares outstanding. The number of shares has decreased by -2.65% in one year.

MedinCell SA’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of MedinCell SA is ―. MedinCell SA’s PEG ratio is ―.

In the last 12 months, MedinCell SA had revenue of 11.95M and earned -25.04M in profits. Earnings per share was -0.88.

In the last 12 months, operating cash flow was -13.30M and capital expenditures -559.00K, giving a free cash flow of -13.86M billion.

MedinCell SA pays an annual dividend of ―, resulting in a dividend yield of ―

MedinCell SA upcoming earnings date is Jun 17, 2025, TBA Not Confirmed.

MedinCell SA as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, MedinCell SA has paid 88.00K in taxes.

MedinCell SA EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

MedinCell SA has €19.46M in cash and marketable securities with €0.00 in debt, giving a net cash position of €39.50M billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for MedinCell SA is €21.65, which is 11.43% higher than the current price. The consensus rating is Moderate Buy